Cardinal Health stock had its Relative Strength (RS) Rating upgraded from 79 to 88 Monday.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
IBD's proprietary RS Rating tracks technical performance by using a 1 (worst) to 99 (best) score that identifies how a stock's price performance over the last 52 weeks matches up against other publicly traded companies.
Over 100 years of market history reveals that the market's biggest winners tend to have an 80 or better RS Rating as they launch their biggest price moves.
Looking For The Best Stocks To Buy And Watch? Start Here
Is Cardinal Health Stock A Buy?
Cardinal Health stock is trying to complete a consolidation with a 64.63 entry. See if the stock can clear the breakout price in heavy trade. Read "Looking For The Next Big Stock Market Winners? Start With These 3 Steps" for more tips.
Earnings grew -5% last quarter, up from -27% in the prior report. Revenue also increased, from 9% to 14%. Look for the next report on or around Aug. 5.
Cardinal Health stock holds the No. 4 rank among its peers in the Medical-Wholesale Drugs industry group. AmerisourceBergen and Cardinal Health are also among the group's highest-rated stocks.
